Deflazacort Oral
Deflazacort Oral is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand name including Deflazacort Oral Suspension. Available dosage form: suspension.
Drug Details
- Generic Name
- Deflazacort Oral
- Brand Names
- Deflazacort Oral Suspension
- Application Number
- ANDA217813
- Sponsor
- Cranbury Pharmaceuticals, LLC
- NDC Codes
- 2
- Dosage Forms
- SUSPENSION
- Routes
- ORAL
- Active Ingredients
- DEFLAZACORT
Indications and Usage
1 INDICATIONS AND USAGE Deflazacort oral suspension is indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 2 years of age and older. Deflazacort oral suspension is a corticosteroid indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 2 years of age and older ( 1 )